The week in health tech, explained in plain English.Get the free newsletter →
October 16, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Healthcare Costs Emerge as Top Midterm Battleground

Healthcare is a defining issue in this year's midterm elections, with cost front and center for voters. A July KFF poll found more than half of voters consider healthcare costs extremely important for candidates to discuss, according to Becker's Hospital Review.

The fights break along familiar lines. Some candidates are reviving Medicare for All proposals, while others are defending or attacking Medicaid cuts that could reshape coverage for millions. Enhanced Affordable Care Act subsidies, set to affect premiums for enrollees, are another flashpoint, along with drug pricing and abortion access. Each issue carries direct financial and operational consequences for hospitals, insurers, and patients.

For healthcare operators, the outcomes matter beyond politics. Medicaid funding decisions influence hospital reimbursement and uncompensated care burdens. ACA subsidy changes affect enrollment and the individual market. Drug pricing policy shapes payer and pharmaceutical strategy. The results will set the regulatory direction for the next two years.

More in Government

Government

Pennsylvania Sues Insulin Makers and PBMs Over Pricing

Pennsylvania's attorney general sued three insulin makers and several PBMs, alleging they colluded to manipulate insulin prices and raise patient costs.

Why it matters: The case adds to mounting legal pressure on insulin pricing and PBM rebate practices that determine what diabetic patients pay at the pharmacy.

Government

CMS Shaped AI Health Policy in a Private Slack

A KFF Health News investigation found CMS used a 1,700-member Slack of tech executives and investors to help shape federal AI healthcare policy outside public channels.

Why it matters: Federal AI rules will govern how healthcare algorithms are paid for and deployed, so who gets private access to shape them affects the entire industry.

Government

NIH Plans National Push on Personalized Cancer Vaccines

The NIH plans a December public-private partnership to accelerate development of personalized cancer vaccines, per a New York Times report.

Why it matters: A federally coordinated effort could accelerate a promising but fragmented field of custom cancer immunotherapies toward wider clinical use.